Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
Ab175476-100μg
|
100μg |
10
|
$79.90
|
|
|
Ab175476-1mg
|
1mg |
4
|
$399.90
|
|
|
Ab175476-5mg
|
5mg |
1
|
$999.90
|
|
|
Ab175476-10mg
|
10mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$1,599.90
|
|
Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG2; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
| Product Name | Bococizumab (anti-PCSK9) - Primary antibody, specific to PCSK9, >95%, high purity, Human IgG2, Antibody of proprotein convertase subtilisin/kexin type 9 |
|---|---|
| Synonyms | Convertase subtilisin/kexin type 9 preproprotein antibody | FH3 antibody | HCHOLA3 antibody | Hypercholesterolemia autosomal dominant 3 antibody | LDLCQ1 antibody | NARC 1 antibody | NARC-1 antibody | NARC1 antibody | Neural apoptosis regulated convertase |
| Specifications & Purity | Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA |
| Host species | Human |
| Specificity | PCSK9 |
| Conjugation | Unconjugated |
| Grade | Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated |
| Action Type | INHIBITOR |
| Mechanism of action | Antibody of proprotein convertase subtilisin/kexin type 9 |
| Product Description |
Bococizumab (anti-PCSK9) is an anti-human PCSK9 inhibitory antibody that reduces LDL cholesterol levels. Bococizumab (anti-PCSK9) can be used in the research of hypercholesterolemia. |
| Isotype | Human IgG2 |
|---|---|
| Light Chain Type | kappa |
| SDS-PAGE | 26.6 kDa (Light Chain) & 51.4 kDa (Heavy Chain), under reducing conditions; 180.0kDa, under non-reducing conditions. |
| Purification Method | Protein A purified |
| Purity | >95% |
| Shape | Liquid |
| Concentration | See COA |
| Storage Temp | Store at -80°C,Avoid repeated freezing and thawing |
| Shipped In | Ice chest + Ice pads |
| Stability And Storage | Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle. |
| CAS | 1407495-02-6 |
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Bococizumab (anti-PCSK9) (Ab175476) - SEC
The purity of Bococizumab (anti-PCSK9) (Ab175476) is more than 95% verified by HPLC.
Bococizumab (anti-PCSK9) (Ab175476) - ELISA
Immobilized hu-PCSK9-chis at 2 μg/mL can bind Bococizumab (anti-PCSK9) (Ab175476) with the EC₅₀ of 6.92 ng/mL.
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | Mar 29, 2024 | Ab175476 | |
| Certificate of Analysis | Mar 29, 2024 | Ab175476 | |
| Certificate of Analysis | Mar 29, 2024 | Ab175476 |
Starting at $109.90
Starting at $109.90
Starting at $109.90
Starting at $109.90
Starting at $109.90
Starting at $109.90
Starting at $109.90